Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress

Heart Rhythm

Volumn 9, Issue 12, 2012, Pages 2023-2031

  Fukunaga, Naoya ^a   Takahashi, Naohiko ^a   Hagiwara, Satoshi ^a   Kume, Osamu ^a   Fukui, Akira ^a   Teshima, Yasushi ^a   Shinohara, Tetsuji ^a   Nawata, Tomoko ^a   Hara, Masahide ^a   Noguchi, Takayuki ^a   Saikawa, Tetsunori ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Chronic kidney disease; Nephrectomy; Oxidative stress

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; COLLAGEN TYPE 1; HISTIDINE; MALONALDEHYDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM ZINC DIHYDROLIPOYLHISTIDINATE; THIOCTIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXPERIMENTAL ANIMAL; FIBROBLAST; GLUCOSE TOLERANCE TEST; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART LEFT ATRIUM; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PERFUSION; HEART RIGHT ATRIUM; HISTOPATHOLOGY; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DYSFUNCTION; MALE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAINING; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ATRIAL FIBRILLATION; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC;

EID: 84870433256     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.08.019     Document Type: Article

References (27)

1. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, D. Levy Impact of atrial fibrillation on the risk of death: the Framingham heart study Circulation 98 1998 946 952
2. A.S. Go, E.M. Hylek, K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (atria) study JAMA 285 2001 2370 2375
3. E.Z. Soliman, R.J. Prineas, A.S. Go Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC) Am Heart J 159 2010 1102 1107
4. H. Watanabe, T. Watanabe, S. Sasaki, K. Nagai, D.M. Roden, Y. Aizawa Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study Am Heart J 158 2009 629 636
5. T. Horio, Y. Iwashima, K. Kamide Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients J Hypertens 28 2010 1738 1744
6. U. Baber, V.J. Howard, J.L. Halperin Association of chronic kidney disease with atrial fibrillation among adults in the united states: Reasons for Geographic and Racial Differences in Stroke (REGARDS) study Circ Arrhythm Electrophysiol 4 2011 26 32
7. V.M. Campese Neurogenic factors and hypertension in chronic renal failure J Nephrol 10 1997 184 187
8. N.D. Vaziri, F. Oveisi, Y. Ding Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension Kidney Int 53 1998 1748 1754
9. N.D. Vaziri, M. Dicus, N.D. Ho, L. Boroujerdi-Rad, R.K. Sindhu Oxidative stress and dysregulation of superoxide dismutase and nadph oxidase in renal insufficiency Kidney Int 63 2003 179 185
10. K. Tsuji-Naito, T. Hatani, T. Okada, T. Tehara Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of dopa conjugate products Bioorg Med Chem 15 2007 1967 1975
11. T. Masuda, Y. Iwashita, S. Hagiwara Dihydrolipoyl histidinate zinc complex, a new antioxidant, attenuates hepatic ischemia-reperfusion injury in rats J Gastroenterol Hepatol 26 2011 1652 1658
12. S. Hagiwara, Y. Teshima, N. Takahashi, H. Koga, T. Saikawa, T. Noguchi New lipoic acid derivative drug sodium zinc dihydrolipoylhistidinate prevents cardiac dysfunction in an isolated perfused rat heart model Crit Care Med 39 2011 506 511
13. O. Wakisaka, N. Takahashi, T. Shinohara Hyperthermia treatment prevents angiotensin ii-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72 J Mol Cell Cardiol 43 2007 616 626
14. S. Ueberberg, J.J. Meier, C. Waengler Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo Diabetes 58 2009 2324 2334
15. O. Kume, N. Takahashi, O. Wakisaka Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats Heart Rhythm 8 2011 278 285
16. Y. Taniguchi, N. Takahashi, A. Fukui Candesartan restored cardiac hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats Cardiovasc Res 92 2011 439 448
17. J. Elkareh, D.J. Kennedy, B. Yashaswi Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy Hypertension 49 2007 215 224
18. Y. Bai, W. Sigala, G.R. Adams, N.D. Vaziri Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease Am J Nephrol 29 2009 213 221
19. Y.M. Kim, H. Kattach, C. Ratnatunga, R. Pillai, K.M. Channon, B. Casadei Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery J Am Coll Cardiol 51 2008 68 74
20. Y.M. Kim, T.J. Guzik, Y.H. Zhang A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation Circ Res 97 2005 629 636
21. J.K. Bendall, A.C. Cave, C. Heymes, N. Gall, A.M. Shah Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin ii-induced cardiac hypertrophy in mice Circulation 105 2002 293 296
22. T. Ago, J. Kuroda, J. Pain, C. Fu, H. Li, J. Sadoshima Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes Circ Res 106 2010 1253 1264
23. J. Kuroda, T. Ago, S. Matsushima, P. Zhai, M.D. Schneider, J. Sadoshima NADPH oxidase 4 (nox4) is a major source of oxidative stress in the failing heart Proc Natl Acad Sci U S A 107 2010 15565 15570
24. R. Bataller, R.F. Schwabe, Y.H. Choi NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis J Clin Invest 112 2003 1383 1394
25. D. Del Rio, A.J. Stewart, N. Pellegrini A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress Nutr Metab Cardiovasc Dis 15 2005 316 328
26. K. Husain, L. Ferder, M. Mizobuchi, J. Finch, E. Slatopolsky Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats Am J Nephrol 29 2009 465 472
27. D.I. Leftheriotis, K.T. Fountoulaki, P.G. Flevari The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation Int J Cardiol 135 2009 361 369